NVA237 BID Versus Placebo Twelve-week Efficacy Study
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
- Status
- COMPLETED
- Phase
- PHASE3
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation
- Status
- COMPLETED
- Phase
- PHASE3
EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes
- Status
- TERMINATED
- Phase
- N/A
A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149
- Status
- COMPLETED
- Phase
- PHASE3
NVA237 Versus Placebo 12-week Efficacy Study
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia
- Status
- COMPLETED
- Phase
- PHASE4
Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMS
- Status
- WITHDRAWN
- Phase
- PHASE4
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®
- Status
- COMPLETED
- Phase
- PHASE4
A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Zoledronic Acid in Cystic Fibrosis
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.
- Status
- COMPLETED
- Phase
- PHASE3
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
- Status
- COMPLETED
- Phase
- PHASE2
Long Term Safety Study of NVA237 vs QAB149 in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study of Oral BGJ398 in Asian Patients
- Status
- COMPLETED
- Phase
- PHASE1